BVF Inc’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,338,678
| Closed | -$239M | – | 76 |
|
|
2021
Q1 | $239M | Buy |
6,338,678
+5,300,000
| +510% | +$132M | 8.95% | 1 |
|
|
2020
Q4 | $17.7M | Sell |
1,038,678
-6,970,675
| -87% | -$87.3M | 0.7% | 36 |
|
|
2020
Q3 | $37.6M | Buy |
8,009,353
+21,300
| +0.3% | +$108K | 2.05% | 21 |
|
|
2020
Q2 | $48.7M | Buy |
7,988,053
+205,052
| +3% | +$845K | 3% | 11 |
|
|
2020
Q1 | $17.7M | Hold |
7,783,001
| – | – | 1.65% | 18 |
|
|
2019
Q4 | $35.7M | Buy |
7,783,001
+4,017,833
| +107% | +$15.9M | 2.71% | 13 |
|
|
2019
Q3 | $14.6M | Buy |
3,765,168
+761,826
| +25% | +$4.18M | 1.53% | 22 |
|
|
2019
Q2 | $18.1M | Sell |
3,003,342
-61,004
| -2% | -$583K | 1.98% | 18 |
|
|
2019
Q1 | $41.1M | Buy |
3,064,346
+283,000
| +10% | +$3.23M | 4.6% | 5 |
|
|
2018
Q4 | $25.9M | Sell |
2,781,346
-599,771
| -18% | -$7.14M | 3.38% | 9 |
|
|
2018
Q3 | $47.1M | Buy |
3,381,117
+2,251,356
| +199% | +$33.5M | 4.14% | 5 |
|
|
2018
Q2 | $17.9M | Buy |
+1,129,761
| New | +$19.7M | 1.74% | 22 |
|
|
2016
Q1 | – | Sell |
-300,000
| Closed | -$12.4M | – | 33 |
|
|
2015
Q4 | $12.4M | Buy |
+300,000
| New | +$10.1M | 2.12% | 18 |
|
|
2015
Q3 | – | Sell |
-240,597
| Closed | -$5.98M | – | 33 |
|
|
2015
Q2 | $5.98M | Sell |
240,597
-262,235
| -52% | -$5.84M | 1.05% | 21 |
|
|
2015
Q1 | $11.5M | Sell |
502,832
-323,500
| -39% | -$8.16M | 2.4% | 17 |
|
|
2014
Q4 | $22.3M | Sell |
826,332
-635,568
| -43% | -$10.9M | 4.34% | 7 |
|
|
2014
Q3 | $17.1M | Buy |
1,461,900
+208,900
| +17% | +$2.64M | 3.56% | 8 |
|
|
2014
Q2 | $19.5M | Buy |
1,253,000
+117,000
| +10% | +$1.68M | 3.08% | 9 |
|
|
2014
Q1 | $22.3M | Buy |
1,136,000
+675,000
| +146% | +$11.5M | 3.46% | 10 |
|
|
2013
Q4 | $7.74M | Buy |
+461,000
| New | +$5.73M | 1.35% | 15 |
|
BVF Inc's FPRX Position: Q2 2021 in Review
BVF Inc sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 6,338,678 shares — an estimated $239M sold.
BVF Inc first reported a position in FPRX in Q4 2013 and held it in 20 quarters. The position peaked at $239M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- BVF Inc reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- BVF Inc sold 6,338,678 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $239M.
- BVF Inc first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 20 quarters.
- BVF Inc's Five Prime Therapeutics, Inc. position peaked at $239M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on BVF Inc's 13F filing for Q2 2021, filed 16 Aug 2021.